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Abstract
Background: Complementary and alternative medicines (CAMs) are being used increasingly across the world. In
Australia, community pharmacists are a major supplier of these products but knowledge of the products and
interactions with other medicines is poor. Information regarding the use of CAMs by metropolitan pharmacists has
been documented by the National Prescribing Service (NPS) in Australia but the views of rural/regional community
pharmacists have not been explored. The aim of this pilot study was to explore the knowledge, attitudes and
information seeking of a cohort of rural community pharmacists towards CAMs and to compare the findings to the
larger NPS study.
Methods: A cross sectional self-administered postal questionnaire was mailed to all community pharmacists in one
rural/regional area of Australia. Using a range of scales, data was collected regarding attitudes, knowledge,
information seeking behaviour and demographics.
Results: Eighty eligible questionnaires were returned. Most pharmacists reported knowing that they should
regularly ask consumers if they are using CAMs but many lacked the confidence to do so. Pharmacists surveyed for
this study were more knowledgeable in regards to side effects and interactions of CAMs than those in the NPS
survey. Over three quarters of pharmacists surveyed reported sourcing CAM information at least several times a
month. The most frequently sought information was drug interactions, dose, contraindications and adverse effects.
A variety of resources were used to source information, the most popular source was the internet but the most
useful resource was CAM text books.
Conclusions: Pharmacists have varied opinions on the use of CAMs and many lack awareness of or access to
good quality CAMs information. Therefore, there is a need to provide pharmacists with opportunities for further
education. The data is valuable in assisting interested stakeholders with the development of initiatives to address
the gaps in attitudes, knowledge and to improve effectiveness of information seeking behaviour.
Background
Complementary and alternative medicines (CAMs) are
defined as ‘herbal medicines, vitamin and mineral sup-
plements, other nutritional supplements, traditional
medicines such as Ayurvedic medicines and traditional
Chinese medicines (TCM), homeopathic medicines and
aromatherapy oils where they make a therapeutic claim’
[1]. CAMs lie outside mainstream medical care within
Australia, however, the popularity of CAMs in Australia
is rising with up to 70% of the population reporting
using some type of CAM [2-7]. Most users of CAMs
believe that the role of the pharmacist should include
the provision of safety information, routine checks for
drug interactions and recommendations of effective
CAMs [7].
Research investigating pharmacists’ attitudes to CAMs
has been conducted within Australia but not specifically
in rural regions [8]. Community pharmacists are one of
the main suppliers of CAMs in Australia responsible for
around 40% of total sales [3,5]. Overall, pharmacists’
attitudes to statements about CAMs indicate they are
cautious and concerned about issues such as safety,
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any medium, provided the original work is properly cited.efficacy and regulation of the medicines [9]. In addition,
pharmacists believe there is a lack of quality information
and limited access to evidence based information [10].
Therefore, they are not confident in discussing these
medicines with their patients [4]. An Australian study
within New South Wales found that pharmacists’ atti-
tudes towards the broader concept of CAMs was posi-
tive [11]. Three-quarters of their respondents believed
that CAMs are a useful supplement to conventional
medicine. Furthermore, a survey of pharmacists in the
United States of America found 80% of respondents
agreed that ‘some herbal or natural products work and
would recommend them to patients’ [12].
There is evidence to suggest that pharmacists’ knowl-
edge is inadequate when counselling patients on CAMs
[13]. Studies in Australia, the United Kingdom, the United
States of America and Singapore have all acknowledged
that pharmacists rate their knowledge and skills to counsel
patients on CAMs as inadequate [6,14-17]. There are
many compounding factors for this lack of knowledge.
Firstly, it is not mandatory to implement CAM teaching
into pharmacy courses and the extent to which CAM is
covered varies [18,19]. It has been found that educational
exposure is directly correlated with the perceived useful-
ness of CAMs [20]. Therefore, students had a balanced
view on the systems of healthcare outside of conventional
medicine [21]. Despite varied teaching, there is a strong
interest in learning more about CAMs at a tertiary level
from both pharmacy and medical students [20,22,23]. Sec-
ondly, Australian pharmacists believe there is a lack of
accurate and easily accessible information, including good
patient resources [13]. Pharmacists sought integrated non-
biased and evidence-based information, especially as many
community pharmacists do not have access to CAM infor-
mation resources [11,13]. It is difficult for pharmacists to
counsel patients on CAMs when the medical fields’ knowl-
edge of drug interactions is lacking [24]. It is these omis-
sions that have been found to negatively impact on
community pharmacists’ knowledge of CAMs [21].
A study examining pharmacists’ attitudes, knowledge and
information seeking behaviour towards CAMs was under-
taken in 2008 by the National Prescribing Service (NPS)[8].
The National Prescribing Service Ltd (NPS) is an indepen-
dent, non-profit organisation funded by the Australian
Government Department of Health and Ageing which
aims to improve quality use of medicines in Australia by
giving people information, skills and knowledge so they
can choose if, when and how to use medicines to attain
better health and wellbeing Almost all of the community
pharmacists surveyed by the NPS had recommended some
kind of CAM in the last 12 months; however, they were
not often involved in CAM sales. The pharmacists’ atti-
tudes were in favour of CAMs needing more scientific test-
ing before using them in conventional medicine. In
addition, less than half of community pharmacists were
confident discussing CAMs with patients. In the NPS study
three CAMs were used to assess knowledge, one which is
commonly used (glucosamine) and two where there is evi-
dence of potential adverse effects and interactions with
conventional medicines (black cohosh and gingko biloba).
The results of the knowledge test showed that based on
self-rated knowledge, two-thirds of pharmacists believed
they had a good working knowledge of glucosamine. One-
third stated they had minimal or no knowledge about black
cohosh and 15% reported having minimal or no knowledge
about gingko biloba. Likewise, actual knowledge of key side
effects and potential drug interactions for these medica-
tions varied greatly. On the subject of information seeking
behaviour by pharmacists, the general consensus was that
they tried to gather CAMs information from a variety of
different sources, however a number of these resources
were considered relatively useless.
Whilst the findings from the NPS study provide some
information and understanding about CAM use and
knowledge the study population was predominately lim-
ited to metropolitan pharmacists, which does not pro-
vide an overview of rural pharmacists. Therefore, the
current study focused solely on a rural population for
the following reasons. Firstly, community pharmacists
play an important role in maintaining rural health
because access to primary health care is often limited in
rural areas [25-28]. Studies in Australia and North
America have reported higher consumption of CAM in
rural populations relative to their urban counterparts
[29,30]. Furthermore, rural populations in Australia are
commonly of lower socio-economic and health status
than those living in urban areas, despite constituting
approximately 32% of the Australian population [31,32].
Secondly, pharmacists working within rural areas often
work independent of other health professionals and
hence are less able to rely on other health professionals
and may have limited access to resources [25-28]. It is
important to ascertain their level of knowledge and their
information seeking behaviour. That way, if deficits in
knowledge are identified then resources may be devel-
oped in order to improve knowledge and additionally,
governing pharmacy bodies can provide support [1]. It
is important to determine the current state of knowl-
edge and attitudes of rural pharmacists towards CAMs,
primarily because they are isolated and require greater
access to resources [33]. It is ultimately the patient who
suffers if the pharmacist is unable to provide the most
appropriate and relevant information.
The aims of this study are to determine rural commu-
nity pharmacists’:
1. Attitudes to CAMs
2. Knowledge of CAMs
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CAMs
The study also seeks to compare the findings with
those derived from the study conducted by the NPS in
2008, which predominately assessed metropolitan com-
munity pharmacists.
Methods
In order to ascertain the views of rural community
pharmacists a pilot study was undertaken using a cross-
sectional questionnaire as part of a quantitative research
design [34]. The aim of the pilot study was to test the
tool used by the NPS for use in this population and to
make some comparisons between the studies. The data
was collected from June to September 2010 using a
cross-sectional self-administered postal questionnaire
distributed to all community pharmacists within the
Loddon Mallee region of Victoria registered with the
Australian Pharmacy Board. This region was selected as
it is the largest rural region in terms of geographic area
within Victoria [35]. This type of study was selected as
there has been little research conducted within Australia
on rural community pharmacists’ and CAMs. and to
assess if the tool was useful for this cohort [36].
Participants
The target population was all community pharmacists
within the Loddon Mallee Region. The population was
selected from a register of all pharmacists within the
region, which totalled 252 people. For the purposes of
this study the pharmacists’ were required to be working
primarily in a community pharmacy within the identi-
fied region. Primarily refers to the area of practice in
which they worked most often, with a cut-off ratio of
2:1 in terms of hours they work. For example, pharma-
cists working in community pharmacy for 20 hours per
week and hospital pharmacy for 10 hours per week have
a ratio of 2:1 and would be classified as community
pharmacists. However, working 15 hours per week in a
community pharmacy and 10 hours per week in a hospi-
tal pharmacy would be a ratio of 1.5:1 and therefore
they were excluded from the study
Data collection
Questionnaires are the most widely used approach by
pharmacy practice researchers, accounting for a higher
proportion of published papers than any other [37,38].
Data was collected via an anonymous, self-administered
postal questionnaire that was adapted from NPS study
[39] (Questionnaire provided as Additional file). All
community pharmacists within the region were sent a
pack that included a questionnaire, reply paid envelope
and participant information sheet. Dillmann’s method of
follow up was utilised in an attempt in order to improve
response rates [40,41]. Potential respondents were con-
tacted a fortnight after the original questionnaire was
mailed out and any non-responders were sent a final
questionnaire two weeks later.
The questionnaire consisted of 26 core questions
which collected demographic and practice related
information. It also included a range of scales to mea-
sure knowledge, experience, attitudes and information
seeking behaviour with regard to CAMs. The response
options varied depending on the types of question
asked and included multiple choice, open-ended ques-
tions and Likert- style scaled responses. The study had
ethical approval from La Trobe University, FHEC 10/
R46.
Data Analysis
The questionnaire responses were analysed using the
Statistical Package for Social Sciences (SPSS) for Win-
dows version 19 and Microsoft Office Excel 2007. Fre-
quencies and percentages of responses were generated
for each answer in the questionnaire. If responses were
continuous and numerical, descriptive statistics were
generated (mean, standard deviation, median, minimum
and maximum). Univariate and bivariate analyses were
conducted to explore CAM recommendations, attitudes,
knowledge and information seeking behaviours. Analyses
of associations between categorical responses using cross
tabulation to compare knowledge of side effects and
drug interactions with recommenders of CAMs were
tested using chi square [42].
Results
Respondents
In total, 252 questionnaires were mailed, 110 were
returned (response rate of 43.6%) Thirty of those were
deemed ineligible as the pharmacists identified that they
were either working part-time or working predominately
in the hospital sector which gave an overall response
rate of 31.7%) The demographic and practice informa-
tion of the respondents are provided in Table 1.
Survey respondents reported practising as pharmacists
for 16.8 years ± 13.2 years and the majority worked full
time (33 hours per week ± 13 hours per week with dis-
tribution negatively skewed; median 38 hours per week).
Nineteen percent worked as consultants or accredited
pharmacists for an average of 9.6 hours per week (SD:
13.2) compared to 14% in the NPS study. Note that
accredited pharmacists are those that are registered with
the Pharmacy Board of Australia. Forty-five percent of
survey respondents, considered that they practised inte-
grative care, defined as ‘a holistic approach to health
care that integrates conventional medical care with com-
plementary therapies’.
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medicine
Pharmacists were asked about their attitudes towards
using CAMs. In the previous 12 months, 77.5% of phar-
macists reported personally using CAMs. Table 2. pro-
vides a summary of pharmacists’ attitudes towards
various statements on CAMs. Further
analysis of the relationship between years of experi-
ence as a pharmacist and confidence in discussing
CAMs with consumers highlighted that those respon-
dents with 9 years or less of experience felt confident in
discussing CAMs with patients. Interestingly, those who
have 25-29 years of experience as a pharmacist were as
confident but many of them also reported completing
post graduate CAM qualifications. The least confident
age group were those who had 10-14 years of experience
as a pharmacist.
Recommendation rates of CAMs in the previous 12
months were high with 95% of pharmacists reporting
recommending CAMs to a consumer. These results
show that whilst a pharmacist may or may not be confi-
dent or adequately equipped with knowledge of CAMs,
they are still recommending them. In other results, 65%
of community pharmacists indicated they were involved
in less than half of the CAMs sales in their community
pharmacy. When they were involved in sales, most com-
munity pharmacists (88.2%) usually recommended the
g e n e r i cn a m eo ft h eC A Mo n l y ,a n df o rt h em i n o r i t y
who recommended specific brands, brand familiarity
was the main influence on their decision.
All of the community pharmacists had discussed CAMs
with patients. However, most of the time it was patient
initiated either in the context where a patient requested
CAMs (95%) or the patient telling the pharmacist they
are taking a CAM (76.25%). Another situation suggested
by respondents was when a pharmacy assistant refers to
the pharmacist during the OTC sale (2.5%).
Knowledge
The results of a knowledge test to be completed without
using references aimed to ascertain what pharmacists
knew about CAMs. The questions assessed self-rated
knowledge, side effects and drug interactions of three
CAMs, one which is commonly used (glucosamine) and
two (black cohosh and gingko biloba) where there is evi-
dence of potential adverse effects and interactions with
conventional medicines.
The results of the self-rated knowledge questions
show that over two thirds of pharmacists believe they
have a good working knowledge of glucosamine, and
one-third knows a little about its uses, side effects and
drug interactions. However, the situation is reversed for
black cohosh and gingko biloba where the majority of
pharmacists indicate they know only minimal details
about these CAMs.
Table 1 Demographic and practice characteristics of
respondents
Demographic and practice
characteristics
Community
pharmacists
(n = 80)
%
Gender Male 35.0
Female 65.0
Age (years) < 35 39.7
35-44 20.5
45-54 25.6
55-64 10.3
≥ 65 3.8
Trained in Australia 90%
Postgraduate CAM qualifications 10%
Table 2 Attitudes of pharmacists towards complementary and alternative medicine
Statements Community pharmacists
(n = 80)
Strongly agree
or
agree
%
Strongly disagree or
disagree
%
Neither agree nor
disagree
%
CAMS need more scientific testing before being used in conventional
medicine
76.3 6.00 15.0
CAMS have a more holistic approach to health than conventional
medicines
40.0 28.8 30.0
Most CAMS are safe and have very few side effects 26.3 53.8 18.8
The results from CAMs are mainly due to a placebo effect 12.5 47.5 35.0
CAMs can offer consumers benefits that conventional medicine cannot 42.6 21.3 35.0
Pharmacists should regularly ask consumers if they are using CAMs 93.8 0.00 5.00
I am confident discussing CAMs therapy with consumers 52.6 31.3 15.0
￿ Not all columns add up to 100% which indicates a lack of response to that question
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side effects are shown in Table 3. 40.3% of pharmacists
were aware of the potential for black cohosh to cause
liver toxicity as an adverse effect. 56.2% of pharmacists
knew that gingko biloba can cause bleeding disorders,
however other potential side effects of the three CAMs
were known by less than half of the pharmacist respon-
dents. For all CAM side effects, those pharmacists who
recommended the specific CAM were more likely to
know of the side effect than non recommenders. How-
ever, this was only statistically significant for pharma-
cists who recommended gingko biloba.
Between 25% and 70% of pharmacists indicated that
they were unsure of the possible side effects of these 3
CAMs. All pharmacists believed there are potential side
effects of black cohosh and only 1.3% believed there
were no side effects associated with using gingko biloba.
However, a significant proportion of pharmacists were
unsure of the potential side effects of glucosamine
(68.4%).
Pharmacists’ knowledge of some potential interactions
between the selected CAMs and some conventional
medicines was also assessed. Over 40% of pharmacists
correctly identified the interaction between glucosamine
and warfarin and 76% were aware of the interaction
between gingko biloba and warfarin. Pharmacists who
recommended the specific CAMs in the last 12 months
were more likely to correctly answer knowledge of drug
interactions.
A significant proportion, between one-third and one-
half, of community pharmacists were unsure of the pos-
sible drug interactions of these three CAMs. All respon-
dents correctly stated there are potential interactions
with black cohosh, however, 48% were still unsure of
the potential interactions. Close to one-fifth of partici-
pants incorrectly indicated there were no potential for
interactions with glucosamine.
Information seeking behaviour
Almost all pharmacists (97.5%) had sought information
about CAMs in the last 12 months. In addition, over
three-quarters of pharmacists sought CAM information
several times a month or more frequently. The most fre-
quently sought after information related to the safety of
CAMs, which included drug interactions (95%), contra-
indications (76%) and adverse effects (75%).
Pharmacists used a wide range of information
resources for finding out information on CAMs. The
most popular were internet searches, MIMS/APP Guide,
specific websites and APF. However, there was disparity
between usage and perceived usefulness of these CAM
resources. The resources ranked highest in terms of use-
fulness were CAM text books, internet searches and
specific websites. A total of 93% of pharmacists had
used the Internet in the last 12 months to seek informa-
tion on CAMs.
Pharmacists were asked to choose, from a list, which
CAMs they would like to have good quality information
on and to indicate any other which was not listed. The
t o pf i v ew e r ec o e n z y m eQ 1 0( 8 1 % ) ,g l u c o s a m i n e( 7 0 % ) ,
fish oil (68%), gingko biloba (68%) and echinacea (60%).
Others included saw palmetto and probiotics at 6.3%.
Discussion
Although other studies have investigated Australian
pharmacists’ experiences with CAMs, this study aimed
to provide a snapshot of the knowledge, attitudes and
information seeking behaviour of a cohort of rural com-
munity pharmacists to CAMs [8]. The results provide a
clear indication of current information gaps that need to
be addressed and it is an important addition to the body
of knowledge of CAMs in relation to community
pharmacists.
The socio-demographic characteristics of participating
community pharmacists as presented in Table 1 are
comparable to national pharmacy workforce data. Sixty
five percent of the respondents were female, 39.7% were
under 35 years of age with more than half being less
that 44 years of age (60.4%). These figures reflect the
national data reported by the Pharmacy Guild of Austra-
lia in their latest workforce planning study [43].
In the current study the age of respondents ranged
from 24 to 74 years (mean age was 40.6 years; SD: 12.9
years). Overall, compared to the NPS study, pharmacists
Table 3 Community pharmacists’ knowledge about specific side effects for three CAMs
CAM side effect Community pharmacists’ knowledge of the side effect
All respondents %
(n = 80)
Recommenders
%
Non- Recommenders
%
Black cohosh - liver problems 40.3 42.3 39.1
Gingko biloba - bleeding disorders 56.2 63.9 48.6
Gingko biloba - seizures 15.1 19.4 10.8
Gingko biloba - dizziness/headache* 49.3 61.0 37.8
Black cohosh - dizziness/headache 27.8 38.5 21.7
NB: N.B.*Difference between non recommenders and recommenders p < 0.01 with a chi square value of 19.9, 4df.
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fore had less professional experience. It was also inter-
esting to note that 19% also worked as consultants or
accredited pharmacists for an average of 9.6 hours per
week (SD: 13.2) compared to 14% in the NPS study.
Only 45% of respondents, compared to approximately
half of NPS respondents, considered that they practised
integrative care, defined as ‘a holistic approach to health
care that integrates conventional medical care with com-
plementary therapies’.F i n a l l y ,t h eN P Ss t u d yh a do n l y
2.7% of respondents who have undertaken postgraduate
CAM qualifications compared to 10% in the current
study.
Attitudes
The findings of this study are similar to many other stu-
dies that have found that many pharmacists lack confi-
dence in discussing CAMs and have concerns with
safety related to poor knowledge [9-12,15,17]. Almost all
pharmacists in the current study agreed that they should
regularly ask consumers if they are using CAMs. How-
ever, only half felt confident in discussing CAM therapy
with consumers. An Australian survey conducted in
2004 found that less than 15% of community pharma-
cists reported feeling very confident in answering enqui-
ries about the safety, interactions, adverse effects and
benefits of CAMs [13]. In the current study there were
a significant proportion of pharmacists who felt CAMs
required further scientific testing before being used in
conventional medicine, as was also the case in the NPS
study. In addition, many pharmacists were concerned
about the safety of CAM use as 57% disagreed that
most CAMs are safe and have very few side effects.
In comparison to the NPS study, participants in the
current study had a greater percentage of pharmacists
strongly agreeing or agreeing that most CAMs are safe
(26.3% versus 17.4% in the NPS study). Between the two
studies, the current study has a lesser percentage of
respondents who were undecided regarding safety of
CAMs. In another study, pharmacists’ believed that
because patients’ perceived CAMs as ‘safe’ and ‘natural, ‘
they were more likely to opt for them rather than con-
ventional medications, which would have been more
effective [8]. Overall, the results of attitudes from the
current study demonstrate that pharmacists are uncer-
tain of the benefits CAMs have to offer, which can in
turn be attributed to a lack of knowledge and
understanding.
Knowledge
During the course of the study, a significant deficit in
the tested knowledge of community pharmacists con-
cerning three common CAMs (black cohosh, glucosa-
mine and gingko biloba) was revealed. Firstly, the lack
of awareness about hepatotoxicity, an adverse effect of
black cohosh, was of particular concern, especially con-
sidering the warnings and numerous publications
regarding adverse reactions [44-46]. Only 40% of phar-
macists were aware of this adverse effect, which was
representative of the results in the NPS study. In addi-
tion, those who are recommending black cohosh were
more likely to know of side effects compared to those
who are not recommending the CAM, 42% and 39%
respectively. Secondly, glucosamine and its potential to
interact with warfarin and cause bleeding has been high-
lighted within literature [47]. However, only 44% were
aware of the interaction and within the NPS study only
38% were aware of the interaction. In addition, 68.4% of
respondents in the current study were not sure of
potential side effects of glucosamine compared to 21.5%
in the NPS study. This is particularly alarming consider-
ing the frequency with which glucosamine was reported
to have been recommended by pharmacists 100% of the
time for either general health, as a preventative or for a
specific condition. Further analysis using chi square to
analyse differences between groups (never recommend-
ing, for general health, as a preventative and for a speci-
fic condition) highlighted those who recommended
glucosamine for a specific condition were less likely to
know of the interaction between glucosamine and war-
farin than those who were recommending it as a pre-
ventative. Speculating that because glucosamine is
generally used in osteoarthritic pain (specific condition)
those pharmacists who were aware of its use as a pre-
ventative had undertaken further research and were
more aware of the drug and specifically the interactions
[48]. Previous Australian research confirms that these
findings regarding knowledge are consistent, as most
pharmacists indicated that their knowledge of CAM
therapies was poor [11]. Likewise, a study in the US
found that pharmacists were more likely to answer cor-
rectly about the uses of CAMs, than adverse effects or
cautions, indicating more information is needed on
potential risks associated with use [49]. In conclusion,
although pharmacists in the current study suggested
they were less aware of side effects and interactions in
comparison to the NPS respondents, this was not the
case. Those in the current study were more knowledge-
able in regards to side effects and interactions of CAMs
than NPS respondents.
Information seeking behaviour
Results from the current study indicate that over three
quarters of pharmacists needed or sought CAM infor-
mation several times or more frequently per month.
This highlights that pharmacists are seeking information
on CAMs and the expectation is that they have ade-
quate resources for their research [33]. In the NPS
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mation at this frequency. The pharmacists used a wide
variety of resources to find information on CAMs, with
the internet being the most popular possibly due to the
ease of access. It would be interesting to have further
investigated the reasons behind the popularity in using
the internet for CAM searches. Furthermore, a disparity
was evident between usage and perceived usefulness of a
list of CAM resources. Those resources which are tradi-
tional sources of medicines information for pharmacists
rated poorly in usefulness for CAM information, for
example dispensing software, MIMS and the Australian
Medicines Handbook. The lack of information in these
conventional resources about CAMs, in addition to lim-
ited training in this area, have both attributed to the
poor knowledge of CAMs displayed in the current
study. In the NPS study, drug information services (DIS)
was the second least likely resource to be used and
when it came to usefulness almost 80% reported it as
useful. Whereas in the current study, pharmacists used
D I So v e r5 0 %o ft h et i m eb u ti tw a so n l yf o u n dt ob e
useful 32% of the time. Finally, in regards to the type of
information pharmacists were seeking, 80% sought
information on doses. This particular finding is of inter-
est because doses are always depicted on the primary
packaging. The use of qualitative methods such as focus
groups or interviews would further explore the reasons
for why pharmacists were requesting information on
doses, perhaps for off label dosing or because they do
not trust the information presented. Although safety of
CAMs was the topic pharmacists most frequently
reported, 67.5% of those in the current study required
information on evidence of effectiveness versus 58.5% in
the NPS study.
To date, no published study has addressed the best
sources for CAM information for use in the community
pharmacy setting. Governing pharmacy bodies can
advance this area by increasing awareness of appropriate
sources for pharmacy premises. Some pharmacists men-
tioned the need for a mandatory CAM text. This reso-
nates with a recent survey of pharmacists in Australia in
which 27% of pharmacists selling CAM believed they
did not have access to CAM information resources such
as textbooks or journals at their place of work [13].
Recent research in the US also indicated that many
community pharmacists are not satisfied with CAM
resources available to them and may not be aware of
some of the higher quality resources [21].
Reliable sources of information are necessary for phar-
macists’ to satisfy the ever increasing demand on CAMs
[50]. The PSA supported this notion through their posi-
tion statement, which recognised the role of pharmacists
in providing CAMs information in order to assist
patient decisions. The statement explicitly stated that
‘pharmacists involved in the supply of such products
have the same obligation to provide information and
advice, consistent with consumer needs, as they do with
registered prescription and proprietary medicines’ [51].
Limitations
As the method involved a self-administered question-
naire, response bias is likely with those displaying
greater awareness of CAMs more likely to respond
[52,53]. The questionnaire response rate is comparable
with other studies examining issues for pharmacists
around CAMs in the United States of America and Aus-
tralia [11,54]. In addition, the current study was found
to have a greater response rate than the NPS study. The
generalisability of the results is limited as the sample of
rural pharmacists was taken from one geographic region
which may not be representative of all rural pharma-
cists. A mixed method study incorporating qualitative
methods such as focus groups or interviews would have
enabled further data to be gathered from the partici-
pants [55,56].
Conclusions
Pharmacists have varied opinions on the use of CAMs,
but the majority studied agree that these medications
are now widely accepted by consumers and that phar-
m a c i s t sh a v ear o l et op l a yi ne n s u r i n gt h a tC A M sa r e
used safely and effectively. Many individuals lacked
awareness of or access to good quality CAMs informa-
tion which suggests that it is important to provide phar-
macists with information on the best resources and
where to access them. In addition, extra opportunities
for further education possibly in the form of continuing
professional development (CPD) points so that they can
better provide advice to consumers on CAM use. The
results also indicate the types of information pharma-
cists desired and how they searched for this information,
however further research into identifying how they
would like to access this information is required. The
findings from this study will be valuable in assisting
interested stakeholders with the development of initia-
tives to address the gaps in attitudes, knowledge and to
improve effectiveness of information seeking behaviour.
The research, thus far, provides important information
regarding rural community pharmacists within the Lod-
d o nM a l l e er e g i o na n dC A M s . Replication of the study
on a larger scale will provide further data relating to
rural pharmacists in general. In conclusion, the discus-
sion draws upon findings to demonstrate how CAMs
are relevant to the professional practice of pharmacists
and highlights the challenges to meeting pharmacists’
knowledge requirements and how the CAMs informa-
tion needs of these health professionals may be
supported.
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Additional file 1: Questionnaire. Copy of the questionnaire adapted
from the NPS for use in this study.
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